COc1ccc(C)cc1N1C(=O)C2ON(Cc3ccc(CC(N)=O)cc3)C(c3c4ccccc4c(Cl)c4ccccc34)C2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?